Jci_page_head_homepage_01 Jci_page_head_homepage_02
Xinmin Xie, Jonathan P. Wisor, Junko Hara, Tara L. Crowder, Robin LeWinter, Taline V. Khroyan, Akihiro Yamanaka, Sabrina Diano, Tamas L. Horvath, Takeshi Sakurai, Lawrence Toll, Thomas S. Kilduff
Published in Volume 118, Issue 7
J Clin Invest. 2008; 118(7):2471–2481 doi:10.1172/JCI35115
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 2
N/OFQ directly hyperpolarizes Hcrt neurons in a dose-depenedent manner.

(A) N/OFQ (1 μM) caused hyperpolarization and a decrease in input resistance in the presence of TTX (0.3 μM), which was used to block synaptic activity and action potentials in an Hcrt-containing cell. (B) In the same neuron, the NOP receptor antagonist SR14148 (10 μM) blocks the N/OFQ-induced hyperpolarization and input resistance decrease. The blockade was reversible after 20-minute washout of the antagonist (data not shown). (C) Since the N/OFQ-induced hyperpolarization apparently did not differ in the presence or absence of TTX, both data sets were pooled to construct a concentration-dependent response curve using the pharmacologic dose-response model-fitting function (OriginPro 7.5; OriginLab). The half-maximal effect of N/OFQ-induced hyperpolarization (EC50) was calculated at 0.329 μM with a Hill coefficient of 1.1. Error bars represent SEM.